«In principle, both these features make GA11 an attractive drug candidate to
target glioma stem - like cells in glioblastoma multiforme tumors,» said Ichiro Nakano, M.D., Ph.D., and colleagues in the paper.
Not exact matches
Small numbers of
glioma stem - like cells, or GSCs, drive the tumorigenicity of GBM and thus are prime
targets for possible treatments.
Nakano says UAB will be the only site in the Deep South for this unique trial aimed at a molecular
target in
glioma stem cells, a
target that is different from the ones described in the Cancer Research paper.
Dario C. Altieri, M.D., Wistar's President and CEO and lead author of the study, and colleagues showed how the activation of this pathway leads to an unfavorable prognosis for patients with
gliomas — a type of brain tumor — and how the pathway could be a valuable therapeutic
target in cancer.
Dr. Sloan said that since a single tumor may contain different pools of
glioma stem cells, combined
targeting should be considered for the pathways and stem cells.
«The field of
targeted therapies in
gliomas holds a lot of promise, and IL13Rα2 is in an optimal position to materialize these promises,» explained corresponding author Sadhak Sengupta, PhD, assistant professor of neurosurgery at BUSM and principal investigator of the Brain Tumor Lab at Roger Williams.
A research team led by Christine Brown, Ph.D., and a clinical team headed by Behnam Badie, M.D., has received a $ 12.8 million grant from the CIRM to fund a phase 1 chimeric antigen receptor (CAR) T cell trial
targeting an aggressive brain cancer called malignant
glioma, which includes glioblastoma.
U-M's internationally renowned Translational Neuro - Oncology Laboratory generates novel primary cell cultures from pediatric and adult
glioma tissue samples to study mechanisms of
glioma growth and
targeted treatment response.
Targeted Wnt7a / 7b deletion or pharmacologic Wnt inhibition blocks Olig2 +
glioma single - cell vessel co-option and enhances responses to temozolomide.
On their surface, the liposomes are studded with proteins that
target receptors on
glioma cells.